HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies.

Abstract
Promising results from pre-clinical studies on the naturally-occurring polyphenol resveratrol have generated considerable interest and somewhat excessive expectations regarding the therapeutic potential of this compound for treating or preventing various diseases, including cardiovascular and neurodegenerative disorders and cancer. Resveratrol has potent inhibitory activity in vitro against various tumor types, including cell lines derived from virtually all blood malignancies. Pharmacological studies have shown that resveratrol is safe for humans but has poor bioavailability, due to its extensive hepatic metabolism. Curiously, a substantial proportion of the orally administered resveratrol can reach the bone marrow compartment. Notably, various pathways dysregulated in blood cancers are known to be molecular targets of resveratrol, thus substantiating the potential utility of this agent in blood malignancies. In this review, we primarily focus on the scientific evidence that supports the potential utility of resveratrol for the management of select hematological malignancies. In addition, potential clinical trials with resveratrol are suggested.
AuthorsJ Luis Espinoza, Yu Kurokawa, Akiyoshi Takami
JournalBlood reviews (Blood Rev) Vol. 33 Pg. 43-52 (01 2019) ISSN: 1532-1681 [Electronic] England
PMID30005817 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2018 Elsevier Ltd. All rights reserved.
Chemical References
  • Antineoplastic Agents, Phytogenic
  • Resveratrol
Topics
  • Animals
  • Antineoplastic Agents, Phytogenic (pharmacology, therapeutic use)
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Clinical Trials as Topic
  • Drug Evaluation, Preclinical
  • Drug Interactions
  • Hematologic Neoplasms (diagnosis, drug therapy, etiology, mortality)
  • Herpesvirus 4, Human (physiology)
  • Humans
  • Immunocompromised Host
  • Resveratrol (pharmacology, therapeutic use)
  • Treatment Outcome
  • Virus Activation (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: